Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitors.
D000818:Animals; D001143:Arousal / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D009434:Neural Pathways / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*
D008996:Monoamine Oxidase Inhibitors; D017981:Receptors, Neurotransmitter; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine